From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.

Bukkems LH, Blanchet B, Arrondeau J, Wislez M, Wang Y, Guchelaar HJ, Smit E, Moes DJAR, Puszkiel A

Open source

DOI
10.1007/s40262-026-01697-3
Published
2026 Sep 6
Container
Clinical pharmacokinetics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40262-026-01697-3,
  title = {From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.},
  author = {Bukkems LH and Blanchet B and Arrondeau J and Wislez M and Wang Y and Guchelaar HJ and Smit E and Moes DJAR and Puszkiel A},
  year = {2026},
  journal = {Clinical pharmacokinetics},
  doi = {10.1007/s40262-026-01697-3},
  url = {https://doi.org/10.1007/s40262-026-01697-3}
}

RIS

TY  - JOUR
TI  - From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.
AU  - Bukkems LH
AU  - Blanchet B
AU  - Arrondeau J
AU  - Wislez M
AU  - Wang Y
AU  - Guchelaar HJ
AU  - Smit E
AU  - Moes DJAR
AU  - Puszkiel A
PY  - 2026
JO  - Clinical pharmacokinetics
DO  - 10.1007/s40262-026-01697-3
UR  - https://doi.org/10.1007/s40262-026-01697-3
ER  - 

APA

LH, B., B, B., J, A., M, W., Y, W., HJ, G., E, S., DJAR, M., & A, P. (2026). From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.. Clinical pharmacokinetics. https://doi.org/10.1007/s40262-026-01697-3

Source records